Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 167

1.

Measurement properties and normative data for the Norwegian SF-36: results from a general population survey.

Garratt AM, Stavem K.

Health Qual Life Outcomes. 2017 Mar 14;15(1):51. doi: 10.1186/s12955-017-0625-9.

2.

The impact of psychological factors on condition-specific, generic and individualized patient reported outcomes in low back pain.

Løchting I, Garratt AM, Storheim K, Werner EL, Grotle M.

Health Qual Life Outcomes. 2017 Feb 21;15(1):40. doi: 10.1186/s12955-017-0593-0.

3.

The Universal Patient Centeredness Questionnaire: scaling approaches to reduce positive skew.

Bjertnaes O, Iversen HH, Garratt AM.

Patient Prefer Adherence. 2016 Nov 3;10:2255-2260. eCollection 2016 Nov 3.

4.

TSHZ3 deletion causes an autism syndrome and defects in cortical projection neurons.

Caubit X, Gubellini P, Andrieux J, Roubertoux PL, Metwaly M, Jacq B, Fatmi A, Had-Aissouni L, Kwan KY, Salin P, Carlier M, Liedén A, Rudd E, Shinawi M, Vincent-Delorme C, Cuisset JM, Lemaitre MP, Abderrehamane F, Duban B, Lemaitre JF, Woolf AS, Bockenhauer D, Severac D, Dubois E, Zhu Y, Sestan N, Garratt AN, Kerkerian-Le Goff L, Fasano L.

Nat Genet. 2016 Nov;48(11):1359-1369. doi: 10.1038/ng.3681. Epub 2016 Sep 26.

5.

The Universal Patient Centeredness Questionnaire: reliability and validity of a one-page questionnaire following surveys in three patient populations.

Bjertnaes O, Iversen HH, Holmboe O, Danielsen K, Garratt A.

Patient Relat Outcome Meas. 2016 Jun 4;7:55-62. doi: 10.2147/PROM.S102732. eCollection 2016 Jun 4.

6.

Rasch analysis of the Norwegian version of the Arthritis Self-Efficacy Scale (ASES).

Garratt AM, Klokkerud M, Løchting I, Hagen KB.

Scand J Rheumatol. 2017 Jan;46(1):33-39. doi: 10.3109/03009742.2016.1155644. Epub 2016 May 17.

PMID:
27187620
7.

Eliciting Patient Risk Willingness in Clinical Consultations as a Means of Improving Decision-Making of Aortic Valve Replacement.

Hussain AI, Garratt AM, Brunborg C, Aakhus S, Gullestad L, Pettersen KI.

J Am Heart Assoc. 2016 Mar 18;5(3):e002828. doi: 10.1161/JAHA.115.002828.

8.

Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury.

Bartus K, Galino J, James ND, Hernandez-Miranda LR, Dawes JM, Fricker FR, Garratt AN, McMahon SB, Ramer MS, Birchmeier C, Bennett DL, Bradbury EJ.

Brain. 2016 May;139(Pt 5):1394-416. doi: 10.1093/brain/aww039. Epub 2016 Mar 17.

PMID:
26993800
9.

Validity of standard gamble utilities in patients referred for aortic valve replacement.

Hussain AI, Garratt AM, Beitnes JO, Gullestad L, Pettersen KI.

Qual Life Res. 2016 Jul;25(7):1703-12. doi: 10.1007/s11136-015-1186-1. Epub 2015 Nov 24.

PMID:
26603737
10.

Evaluation of the stages of completion and scoring of the Patient Generated Index (PGI) in patients with rheumatic diseases.

Garratt AM.

Qual Life Res. 2015 Nov;24(11):2625-35. doi: 10.1007/s11136-015-1014-7. Epub 2015 Jun 3.

PMID:
26038215
11.

Tshz1 Regulates Pancreatic β-Cell Maturation.

Raum JC, Soleimanpour SA, Groff DN, Coré N, Fasano L, Garratt AN, Dai C, Powers AC, Stoffers DA.

Diabetes. 2015 Aug;64(8):2905-14. doi: 10.2337/db14-1443. Epub 2015 Apr 27.

12.

Individualized quality of life in patients with low back pain: reliability and validity of the Patient Generated Index.

Løchting I, Grotle M, Storheim K, Werner EL, Garratt AM.

J Rehabil Med. 2014 Sep;46(8):781-7. doi: 10.2340/16501977-1826.

13.

Activation of MAPK overrides the termination of myelin growth and replaces Nrg1/ErbB3 signals during Schwann cell development and myelination.

Sheean ME, McShane E, Cheret C, Walcher J, Müller T, Wulf-Goldenberg A, Hoelper S, Garratt AN, Krüger M, Rajewsky K, Meijer D, Birchmeier W, Lewin GR, Selbach M, Birchmeier C.

Genes Dev. 2014 Feb 1;28(3):290-303. doi: 10.1101/gad.230045.113.

14.

TSHZ1-dependent gene regulation is essential for olfactory bulb development and olfaction.

Ragancokova D, Rocca E, Oonk AM, Schulz H, Rohde E, Bednarsch J, Feenstra I, Pennings RJ, Wende H, Garratt AN.

J Clin Invest. 2014 Mar;124(3):1214-27.

15.
16.

Measurement properties of instruments assessing self-efficacy in patients with rheumatic diseases.

Garratt AM, Løchting I, Smedslund G, Hagen KB.

Rheumatology (Oxford). 2014 Jul;53(7):1161-71. doi: 10.1093/rheumatology/ket374. Epub 2013 Nov 18. Review.

PMID:
24249031
17.

Wnt/Rspondin/β-catenin signals control axonal sorting and lineage progression in Schwann cell development.

Grigoryan T, Stein S, Qi J, Wende H, Garratt AN, Nave KA, Birchmeier C, Birchmeier W.

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18174-9. doi: 10.1073/pnas.1310490110. Epub 2013 Oct 22.

18.

Which Roland-Morris Disability Questionnaire? Rasch analysis of four different versions tested in a Norwegian population.

Grotle M, Wilkens P, Garratt AM, Scheel I, Storheim K.

J Rehabil Med. 2013 Jul;45(7):670-7. doi: 10.2340/16501977-1166.

19.

Axonal neuregulin 1 is a rate limiting but not essential factor for nerve remyelination.

Fricker FR, Antunes-Martins A, Galino J, Paramsothy R, La Russa F, Perkins J, Goldberg R, Brelstaff J, Zhu N, McMahon SB, Orengo C, Garratt AN, Birchmeier C, Bennett DL.

Brain. 2013 Jul;136(Pt 7):2279-97. doi: 10.1093/brain/awt148.

20.

Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles.

Cheret C, Willem M, Fricker FR, Wende H, Wulf-Goldenberg A, Tahirovic S, Nave KA, Saftig P, Haass C, Garratt AN, Bennett DL, Birchmeier C.

EMBO J. 2013 Jul 17;32(14):2015-28. doi: 10.1038/emboj.2013.146. Epub 2013 Jun 21.

Supplemental Content

Loading ...
Support Center